Return to Statistics Toolbox

OPLS-DA analysis for Study ST002024

(Analysis AN003294 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Treatment:20190304-Blank
Treatment:20190304-LipL2_AP_acetate
Treatment:20190304-LipL2_AP_glucose
Treatment:20190304-LipL2_AP_glutamine
Treatment:20190304-QC
Treatment:20190304-WT_AP_acetate
Treatment:20190304-WT_AP_glucose
Treatment:20190304-WT_AP_glutamine
Treatment:20190313-Blank
Treatment:20190313-LipL2_acetate
Treatment:20190313-LipL2_glucose
Treatment:20190313-LipL2_glutamine
Treatment:20190313-QC
Treatment:20190313-WT_acetate
Treatment:20190313-WT_glucose
Treatment:20190313-WT_glutamine
Treatment:20190401-Blank
Treatment:20190401-LipL2-glucose
Treatment:20190401-LipL2-glutamine
Treatment:20190401-QC
Treatment:20190401-WT-glucose
Treatment:20190401-WT-glutamine
Treatment:20191107-BKE2_glucose
Treatment:20191107-BKE2_glutamine
Treatment:20191107-Blank
Treatment:20191107-QC
Treatment:20191107-WT_glucose
Treatment:20191107-WT_glutamine
Treatment:20191120-BKE2_glucose
Treatment:20191120-BKE2_glutamine
Treatment:20191120-Blank
Treatment:20191120-QC
Treatment:20191216-Blank
Treatment:20191216-LipL2-glucose
Treatment:20191216-LipL2-glutamine
Treatment:20191216-QC
Treatment:20191216-WT-glucose
Treatment:20191216-WT-glutamine
Treatment:20200810-BE12-Glucose-B1
Treatment:20200810-BE12-Glucose-B2
Treatment:20200810-BE12-Glutamine-B1
Treatment:20200810-BE12-Glutamine-B2
Treatment:20200810-Blank
Treatment:20200810-QC

  logo